| Pharmaceutical Information |
| Drug Name |
Nizatidine |
| Drug ID |
BADD_D01582 |
| Description |
A histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers. |
| Indications and Usage |
For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer. |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB00585
|
| KEGG ID |
D00440
|
| MeSH ID |
D016567
|
| PubChem ID |
3033637
|
| TTD Drug ID |
D0Q9DK
|
| NDC Product Code |
72643-018; 55111-310; 0591-3138; 0591-3137; 63187-249; 68462-425; 55111-011; 68462-426; 60846-301; 55111-311 |
| UNII |
P41PML4GHR
|
| Synonyms |
Nizatidine | N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine | LY-139037 | LY 139037 | LY139037 | Axid |
|
| Chemical Information |
| Molecular Formula |
C12H21N5O2S2 |
| CAS Registry Number |
76963-41-2 |
| SMILES |
CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
